Continuous Glucose Monitoring in Hospitalized Patients With Type 2 Diabetes: A Step Forward in Inpatient Glycemic Control
Authors' conclusion
The implementation of CGM in hospitals could represent a significant advancement in diabetes management, offering a more comprehensive and dynamic approach to monitoring glucose levels. Further research is needed to explore the long-term impacts of CGM on clinical outcomes and to optimize its integration into hospital protocols.
Study context
- Population
- Hospitalized patients with T2D in medical and surgical wards; all used continuous glucose monitoring (CGM) (Abbott FreeStyle2 or FreeStyle3) and 6-point point of care glucose
- Participants
- 37 patients
- Comparison
- CGM-guided vs point of care glucose-guided glycemic therapeutic decisions
- An = 19
- Bn = 18reference
- Primary endpoint
- Difference in TIR 70-180 mg/dL, hospital glycemia risk index, TBR (<70 and <54 mg/dL) and TAR (>180 and >250 mg/dL)
Methodological detailspilot
- Pilot
Primary result
As reported in the abstract
TIR 70-180 mg/dL
P = 0.04
Further findings
TAR level 1
P = 0.04
| Outcome | A | B | P value |
|---|---|---|---|
| Asymptomatic hypoglycemic events detectedMore detected with A | mean 1.65 ± 2.03 | mean 0.31 ± 0.60 | P = 0.01 |
CGM accuracy
- Overall mean absolute relative difference
- 14.7%
- Diabetes technology society error grid zone A
- 69.5%
- Diabetes technology society error grid zone B
- 29.3%
Original publication
Continuous Glucose Monitoring in Hospitalized Patients With Type 2 Diabetes: A Step Forward in Inpatient Glycemic Control. Endocr Pract. Published 13 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →